These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2051260)
1. The L6 muscle cell line as a tool to evaluate parenteral products for irritation. Laska DA; Williams PD; Reboulet JT; Morris RM J Parenter Sci Technol; 1991; 45(2):77-82. PubMed ID: 2051260 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of pain and irritation following local administration of parenteral formulations using the rat paw lick model. Gupta PK; Patel JP; Hahn KR J Pharm Sci Technol; 1994; 48(3):159-66. PubMed ID: 8069518 [TBL] [Abstract][Full Text] [Related]
3. An in vitro model for assessing muscle irritation due to parenteral antibiotics. Williams PD; Masters BG; Evans LD; Laska DA; Hottendorf GH Fundam Appl Toxicol; 1987 Jul; 9(1):10-7. PubMed ID: 3622955 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone effects on creatine kinase activity and insulin-like growth factor receptors in cultured muscle cells. Whitson PA; Stuart CA; Huls MH; Sams CF; Cintron NM J Cell Physiol; 1989 Jul; 140(1):8-17. PubMed ID: 2544617 [TBL] [Abstract][Full Text] [Related]
5. In vitro correlation of ultrastructural morphology and creatine phosphokinase release in L6 skeletal muscle cells after exposure to parenteral antibiotics. Laska DA; Williams PD; White SL; Thompson CA; Hoover DM In Vitro Cell Dev Biol; 1990 Apr; 26(4):393-8. PubMed ID: 2345125 [TBL] [Abstract][Full Text] [Related]
6. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
8. Isozymes of creatine kinase in mammalian cell cultures. Van Brussel E; Yang JJ; Seraydarian MW J Cell Physiol; 1983 Aug; 116(2):221-6. PubMed ID: 6863402 [TBL] [Abstract][Full Text] [Related]
10. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective. Buckley LA; Dorato MA Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212 [TBL] [Abstract][Full Text] [Related]
11. Verapamil-induced creatine kinase loss from rat slow and fast muscles. Glenn GM; Hayes DA; Armstrong RB Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):353-6. PubMed ID: 2236901 [TBL] [Abstract][Full Text] [Related]
12. In vitro - in vivo correlation: from theory to applications. Emami J J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187 [TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
14. Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal models. Sutton SC; Evans LA; Rinaldi MT; Norton KA Pharm Res; 1996 Oct; 13(10):1514-8. PubMed ID: 8899843 [TBL] [Abstract][Full Text] [Related]
15. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy. Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603 [TBL] [Abstract][Full Text] [Related]
16. Pain on injection and muscle irritation: a comparison of animal models for assessing parenteral antibiotics. Comereski CR; Williams PD; Bregman CL; Hottendorf GH Fundam Appl Toxicol; 1986 Feb; 6(2):335-8. PubMed ID: 3699322 [TBL] [Abstract][Full Text] [Related]
17. Rat epidermal keratinocyte organotypic culture (ROC) as a model for chemically induced skin irritation testing. Pappinen S; Pasonen-Seppänen S; Suhonen M; Tammi R; Urtti A Toxicol Appl Pharmacol; 2005 Nov; 208(3):233-41. PubMed ID: 16239167 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
19. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
20. [Physicochemical incompatibilities of injectable drugs]. Hoffman M; Hazebroucq G Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899 [No Abstract] [Full Text] [Related] [Next] [New Search]